Infectious Diseases

Research

Information/Contact
Contact Information
Close
Division: 
Infectious Disease
Director: 
Anne A. Gershon, MD
Email: 
aag1@columbia.edu
Phone: 
(212) 304-9445
Administrator: 
Lubna Shamsi, MPH
Phone: 
(212) 305-5831
Fax: 
(212) 342-5756
  • Varicella Zoster in the enteric nervous system, pathogenesis and consequences. Study of latency and reactivation in humans and animal models, leading to gastroenterological diseases. Anne Gershon, MD (NIH: RO1DK093094)
  • Calcium dependent signaling in airway epithelial cells. Alice Prince, MD (NIH: RO1HL073989)
  • Staphlococcus Aureus activation of the signaling pathway. Alice Prince, MD (NIH: RO1HL079395)
  • Gardnerella Vaginalis: Toxin production and pathogenesis: To examine and prevent reproductive tract infections and early birth. Adam Ratner, MD, MPH (NIH RO1A1092743)
  • Initiation of Antiretroviral Therapy in Behaviorally-infected youth with HIV. Natalie Neu, MD, MPH
  • Knowledge, attitude, and practice survey of providers initiating antiretroviral therapy in HIV infected youth. Natalie Neu, MD, MPH
  • Use and outcomes for pediatric patients treated with caspofungin for candidemia. Natalie Neu, MD, MPH
  • Interdisciplinary research for improving antibiotic prescribing in the NICU: To examine antimicrobial prescribing in the neonatal intensive care unit. Lisa Saiman, MD MPH (NIH Ro1NRO10821)
  • Hand hygiene and interventions for long term care. Lisa Saiman, MD MPH
  • Evaluation of and intervention to improve antimicrobial prophylaxis in pediatric surgery.
  • Studies with varicella vaccine: To examine the safety of VZV vaccines in children and in adults. Anne Gershon, MD
  • A randomized, placebo controlled clinical trial of azithromycin in children and adolescents with Cystic Fibrosis who are not yet infected with P. aeruginosa: To develop a web-based cell phone program to improve adherence by young adolescents MRSA in Cystic Fibrosis: To assesses the molecular epidemiology and risk factors for MRSA in children and adolescents and to evaluate microbial diversity and ecology in cystic fibrosis. Paul Planet, MD, PhD